What is the recommended dose of epinephrine (adrenaline) for treating anaphylaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Epinephrine Dosing for Anaphylaxis

For adults and children ≥30 kg, administer 0.3 to 0.5 mg of epinephrine (1:1000 concentration) intramuscularly into the anterolateral thigh, repeated every 5 to 15 minutes as needed; for children <30 kg, give 0.01 mg/kg (maximum 0.3 mg) intramuscularly. 1, 2, 3

Adult Dosing

  • Administer 0.3 to 0.5 mg (0.3 to 0.5 mL of 1:1000 concentration) intramuscularly into the anterolateral aspect of the thigh as recommended by the American Heart Association and FDA labeling 1, 2, 3
  • Repeat doses every 5 to 15 minutes based on patient response, with approximately 6-19% of patients requiring a second dose 1, 2
  • The FDA label specifies every 5 to 10 minutes for repeat dosing 3

Pediatric Dosing

Children ≥30 kg (66 lbs)

  • Use the same adult dose: 0.3 to 0.5 mg intramuscularly 2, 3

Children <30 kg (66 lbs)

  • Administer 0.01 mg/kg (0.01 mL/kg of 1:1000 concentration) up to a maximum of 0.3 mg intramuscularly 1, 2, 3
  • For autoinjector selection: 0.15 mg autoinjector for children weighing 7.5 to 25 kg, and 0.3 mg autoinjector for children ≥25 kg 2
  • Repeat every 5 to 15 minutes as necessary 1, 2

Route of Administration

Intramuscular injection into the anterolateral thigh (vastus lateralis muscle) is the preferred first-line route, producing rapid peak plasma concentrations compared to subcutaneous administration 1, 2

When to Use IV Epinephrine

  • Reserve intravenous epinephrine for patients in anaphylactic shock when IV access is already established, or for cardiac arrest or profound hypotension unresponsive to IM epinephrine and fluid resuscitation 1, 2
  • IV dose: 0.05 to 0.1 mg (0.5 to 1 mL of 1:10,000 solution) 2
  • For continuous IV infusion: add 1 mg (1 mL of 1:1000) to 1000 mL of 0.9% normal saline, starting at 2 μg/min (120 mL/h) and titrating up to 10 μg/min (600 mL/h) based on blood pressure, heart rate, and oxygenation 1, 2

Critical Safety Points

No Absolute Contraindications

  • There are no absolute contraindications to epinephrine use in anaphylaxis, even in elderly patients with cardiovascular disease or other comorbidities, as the benefits far outweigh the risks according to the American Academy of Allergy, Asthma, and Immunology 1, 2, 4, 3
  • Common adverse effects include transient pallor, tremor, anxiety, palpitations, sweating, and headache 1, 3
  • Mortality from anaphylaxis is remarkably low at less than 0.5% per episode when treated appropriately with epinephrine 4

Common Pitfalls to Avoid

Do not withhold epinephrine due to fear of adverse effects—delay in administration is associated with increased morbidity and mortality 1, 4

Do not inject into buttocks, digits, hands, or feet as specified by FDA labeling 3

Avoid dosing errors: The most dangerous error is administering the cardiac arrest dose (1 mg IV push) instead of the anaphylaxis dose (0.3-0.5 mg IM), which can cause severe cardiac complications including ventricular dysfunction 5

Recognize the concentration difference:

  • IM/subcutaneous use requires 1:1000 concentration (1 mg per 1 mL) 2
  • IV use requires 1:10,000 concentration to avoid overdose 2

Special Population Considerations

  • Fixed autoinjector doses may lead to potential overdosing in small children (<15 kg) or underdosing in larger adolescents and obese adults 4, 6, 7
  • Patients requiring more than one dose are more likely to require hospital admission 4
  • Elderly patients and pregnant women may be at greater risk of adverse reactions but should still receive epinephrine without hesitation 3

References

Guideline

Anaphylaxis Management with Epinephrine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Anaphylaxis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Anaphylaxis Management with Epinephrine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Epinephrine, auto-injectors, and anaphylaxis: Challenges of dose, depth, and device.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2018

Research

International recommendations on epinephrine auto-injector doses often differ from standard weight-based guidance: a review and clinical proposals.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.